FDA Companion, Co-Development Dx Guidances On Track, Official Says
This article was originally published in The Gray Sheet
Executive Summary
FDA aims to issue both a final companion diagnostics guidance document and a separate draft guidance on the co-development of drugs and tests in the coming months.